CTLA4 and cancer: Serum levels of sCTLA-4 are high in several cancers, but it has only recently been identified to have an immunosuppressive capacity like recombinant CTLA4-Ig, an inhibitory costimulatory modulator used to treat rheumatoid arthritis [13,14].